Rare Coexistence of Endobronchial Tuberculosis and Bronchial Carcinoid Tumor: A Diagnostic Challenge.

Ann Afr MedJul 30, 2026 (epub)

L Shreya, V Jereen, A Arthi et al.

✦ AI-curated · Sources linked

Case in brief

A 57-year-old woman presented with respiratory symptoms and constitutional features suggestive of tuberculosis. Imaging showed a right hilar mass with airway compromise, and bronchoscopy identified an obstructive endobronchial lesion. Cartridge-based nucleic acid amplification testing confirmed tuberculosis; elevated serum chromogranin levels raised suspicion of a coexisting bronchial carcinoid. She began anti-tubercular therapy, with further oncological evaluation planned to clarify the lesion.

What made this case unusual

The diagnostic challenge was the coexistence of microbiologically confirmed endobronchial tuberculosis and a suspected carcinoid in an obstructive lesion, with the tumor not yet established in the report.

Diagnostic / clinical pearl

A positive test for endobronchial tuberculosis may not fully explain an obstructive lesion or hilar mass; consider concurrent pathology and integrate microbiological, bronchoscopic, imaging, and tumor-marker findings.

Source

Published in Ann Afr Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pulmonology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.